These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Seroconversion after measles vaccination at nine and fifteen months of age. Işik N, Uzel N, Gökçay G, Kiliç A, Yilmaz G, Sadikoğlu B, Diri S. Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768 [Abstract] [Full Text] [Related]
5. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE. J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100 [Abstract] [Full Text] [Related]
6. Humoral and cellular immune response after measles vaccination in Taiwan. Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL. J Microbiol Immunol Infect; 2005 Jun 01; 38(3):169-75. PubMed ID: 15986066 [Abstract] [Full Text] [Related]
7. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Vesikari T, Baer M, Willems P. Pediatr Infect Dis J; 2007 Feb 01; 26(2):153-8. PubMed ID: 17259879 [Abstract] [Full Text] [Related]
16. Predicting and comparing long-term measles antibody profiles of different immunization policies. Lee MS, Nokes DJ. Bull World Health Organ; 2001 Jun 01; 79(7):615-24. PubMed ID: 11477964 [Abstract] [Full Text] [Related]
17. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody. Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad. Pediatr Infect Dis J; 2006 Jul 01; 25(7):615-22. PubMed ID: 16804432 [Abstract] [Full Text] [Related]
18. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants. D'Angio CT, Boohene PA, Mowrer A, Audet S, Menegus MA, Schmid DS, Beeler JA. Pediatrics; 2007 Mar 01; 119(3):e574-9. PubMed ID: 17332177 [Abstract] [Full Text] [Related]
19. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. Halsey NA, Boulos R, Mode F, Andre J, Bowman L, Yaeger RG, Toureau S, Rohde J, Boulos C. N Engl J Med; 1985 Aug 29; 313(9):544-9. PubMed ID: 4022091 [Abstract] [Full Text] [Related]
20. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine. Gillet Y, Steri GC, Behre U, Arsène JP, Lanse X, Helm K, Esposito S, Meister N, Desole MG, Douha M, Willems P. Vaccine; 2009 Jan 14; 27(3):446-53. PubMed ID: 19007835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]